American Journal of Kidney Diseases
Volume 38, Issue 2 , Pages 371-376, August 2001

Short daily hemodialysis: Blood pressure control and left ventricular mass reduction in hypertensive hemodialysis patients

From the Departments of Nephrology-Dialysis and Cardiology, Silvestrini Hospital; Department of Internal Medicine, University of Perugia, Perugia, Italy; and the Endocrinology Unit, University Hospital, Gent, Belgium.

Received 12 September 2000

Abstract 

Several retrospective and uncontrolled prospective studies reported blood pressure (BP) normalization and left ventricular mass (LVM) reduction during daily hemodialysis (DHD). Conversely, the burden of these major independent risk factors is only marginally reduced by the initiation of standard thrice-weekly dialysis (SHD), and cardiovascular events still represent the most common cause of death in hemodialysis patients. Therefore, we performed a randomized two-period crossover study to compare the effect of short DHD versus SHD on BP and LVM in hypertensive patients with end-stage renal disease. We studied 12 hypertensive patients who had been stable on SHD treatment for more than 6 months. At the end of 6 months of SHD and 6 months of DHD in a sequence of randomly assigned 24-hour ambulatory BP monitoring, echocardiography and bioimpedance were performed. Throughout the study, patients maintained the same Kt/V. A significant reduction in 24-hour BP during DHD was reported (systolic BP [lsqb ]SBP[rsqb ]: DHD, 128 [plusmn] 11.6 mm Hg; SHD, 148 [plusmn] 19.2 mm Hg; P [lt ] 0.01; diastolic BP: DHD, 67 [plusmn] 8.3mm Hg; SHD, 73 [plusmn] 5.4 mm Hg; P [equals] 0.01). The decrease in BP was accompanied by the withdrawal of antihypertensive therapy in 7 of 8 patients during DHD (P [lt ] 0.01). LVM index (LVMI) decreased significantly during DHD (DHD, 120.1 [plusmn] 60.4 g/m2; SHD, 148.7 [plusmn] 59.7 g/m2; P [equals] 0.01). Extracellular water (ECW) content decreased from 52.7% [plusmn] 11.4% to 47.6% [plusmn] 7.5% (P [equals] 0.02) and correlated with 24-hour SBP (r [equals] 0.63; P [lt ] 0.01) and LVMI (r [equals] 0.66; P [lt ] 0.01). In conclusion, this prospective crossover study confirms that DHD allows optimal control of BP, reduction in LVMI, and withdrawal of antihypertensive treatment. These effects seem to be related to reduction in ECW content. [copy ] 2001 by the National Kidney Foundation, Inc.

No full text is available. To read the body of this article, please view the PDF online.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0272-6386(01)39599-9

doi:10.1053/ajkd.2001.26103

American Journal of Kidney Diseases
Volume 38, Issue 2 , Pages 371-376, August 2001